Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-01-09 Sale |
2023-01-11 6:15 pm |
PTC THERAPEUTICS INC. | PTCT | Hill Emily Luisa CHIEF FINANCIAL OFFICER |
758 | $41.66 | $31,575 | 48,001 (Direct) |
View |
2023-01-09 Sale |
2023-01-11 6:14 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
835 | $41.66 | $34,783 | 77,275 (Direct) |
View |
2023-01-09 Sale |
2023-01-11 6:13 pm |
PTC THERAPEUTICS INC. | PTCT | Klein Matthew B. CHIEF OPERATING OFFICER |
731 | $41.66 | $30,451 | 82,373 (Direct) |
View |
2023-01-09 Sale |
2023-01-11 6:12 pm |
PTC THERAPEUTICS INC. | PTCT | Pauwels Eric CHIEF BUSINESS OFFICER |
858 | $41.66 | $35,741 | 67,505 (Direct) |
View |
2023-01-09 Sale |
2023-01-11 6:11 pm |
PTC THERAPEUTICS INC. | PTCT | Peltz Stuart Walter CHIEF EXECUTIVE OFFICER |
2,065 | $41.66 | $86,020 | 228,250 (Indirect Direct) |
View |
2023-01-09 Sale |
2023-01-11 6:10 pm |
PTC THERAPEUTICS INC. | PTCT | Utter Christine Marie SVP, FINANCE & CAO |
706 | $41.66 | $29,409 | 39,290 (Direct) |
View |
2022-10-17 Sale |
2022-10-19 4:09 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
6,901 | $55 | $379,572 | 664,691 (Direct) |
View |
2022-09-20 Sale |
2022-09-22 4:38 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
1,176 | $55 | $64,680 | 547,658 (Direct) |
View |
2022-08-09 Sale |
2022-08-11 4:28 pm |
PTC THERAPEUTICS INC. | PTCT | Okey Stephanie Director |
2,296 | $51.62 | $118,522 | 1,867 (Direct) |
View |
2022-06-09 Sale |
2022-06-10 4:06 pm |
PTC THERAPEUTICS INC. | PTCT | Svoronos Dawn Director |
738 | $27.2 | $20,074 | 29,017 (Direct) |
View |
2022-06-07 Sale |
2022-06-09 4:03 pm |
PTC THERAPEUTICS INC. | PTCT | Peltz Stuart Walter CHIEF EXECUTIVE OFFICER |
407 | $26.83 | $10,919 | 38,239 (Indirect) |
View |
2022-04-19 Sale |
2022-04-21 4:03 pm |
PTC THERAPEUTICS INC. | PTCT | Klein Matthew B. CHIEF OPERATING OFFICER |
897 | $42.52 | $38,136 | 56,564 (Direct) |
View |
2022-04-19 Sale |
2022-04-21 4:02 pm |
PTC THERAPEUTICS INC. | PTCT | Pauwels Eric CHIEF BUSINESS OFFICER |
822 | $42.52 | $34,947 | 49,772 (Direct) |
View |
2022-04-14 Sale |
2022-04-15 4:04 pm |
PTC THERAPEUTICS INC. | PTCT | Peltz Stuart Walter CHIEF EXECUTIVE OFFICER |
82 | $45.28 | $3,713 | 38,646 (Indirect) |
View |
2022-04-13 Sale |
2022-04-15 4:02 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
2,276 | $45.17 | $102,811 | 479,710 (Direct) |
View |
2022-04-05 Sale |
2022-04-07 4:03 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
5 | $45 | $225 | 481,986 (Direct) |
View |
2022-03-31 Sale |
2022-04-01 4:20 pm |
PTC THERAPEUTICS INC. | PTCT | Hill Emily Luisa CHIEF FINANCIAL OFFICER |
7,910 | $37.78 | $298,824 | 29,259 (Direct) |
View |
2022-02-10 Sale |
2022-02-11 4:11 pm |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
17,935 | $45.03 | $807,559 | 481,991 (Direct) |
View |
2022-02-01 Sale |
2022-02-03 4:59 pm |
PTC THERAPEUTICS INC. | PTCT | Utter Christine Marie SVP, Finance & CAO |
1,020 | $40.26 | $41,069 | 25,405 (Direct) |
View |
2022-02-01 Sale |
2022-02-03 4:58 pm |
PTC THERAPEUTICS INC. | PTCT | Peltz Stuart Walter Chief Executive Officer |
2,243 | $40 | $89,724 | 159,213 (Indirect Direct) |
View |
2022-02-01 Sale |
2022-02-03 4:58 pm |
PTC THERAPEUTICS INC. | PTCT | Pauwels Eric Chief Business Officer |
367 | $40 | $14,681 | 50,594 (Direct) |
View |
2022-02-01 Sale |
2022-02-03 4:58 pm |
PTC THERAPEUTICS INC. | PTCT | Hill Emily Luisa Chief Financial Officer |
553 | $40 | $22,121 | 37,169 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-01-05 Option Award |
2023-01-09 4:58 pm |
N/A 2033-01-04 |
PTC THERAPEUTICS INC. | PTCT | Utter Christine Marie SVP, FINANCE & CAO |
46,500 | $0 | 72,496 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 4:58 pm |
N/A 2033-01-04 |
PTC THERAPEUTICS INC. | PTCT | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER |
53,960 | $0 | 105,829 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 4:56 pm |
N/A 2033-01-04 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
53,250 | $0 | 114,360 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 4:55 pm |
N/A 2033-01-04 |
PTC THERAPEUTICS INC. | PTCT | Hill Emily Luisa CHIEF FINANCIAL OFFICER |
62,000 | $0 | 91,259 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 4:54 pm |
N/A 2033-01-04 |
PTC THERAPEUTICS INC. | PTCT | Pauwels Eric CHIEF BUSINESS OFFICER |
63,000 | $0 | 113,363 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 4:52 pm |
N/A 2033-01-04 |
PTC THERAPEUTICS INC. | PTCT | Klein Matthew B. CHIEF OPERATING OFFICER |
91,000 | $0 | 148,104 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 4:51 pm |
N/A 2033-01-04 |
PTC THERAPEUTICS INC. | PTCT | Peltz Stuart Walter CHIEF EXECUTIVE OFFICER |
248,500 | $0 | 407,815 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 4:27 pm |
N/A 2033-01-04 |
PTC THERAPEUTICS INC. | PTCT | SCHMERTZLER MICHAEL Director |
28,000 | $0 | 137,766 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 4:17 pm |
N/A 2033-01-04 |
PTC THERAPEUTICS INC. | PTCT | Jacobson Allan Steven Director |
14,000 | $0 | 22,348 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 4:16 pm |
N/A 2033-01-04 |
PTC THERAPEUTICS INC. | PTCT | ZELDIS JEROME B Director |
14,000 | $0 | 20,500 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 4:14 pm |
N/A 2033-01-04 |
PTC THERAPEUTICS INC. | PTCT | Young Alethia Director |
14,000 | $0 | 19,067 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 4:13 pm |
N/A 2033-01-04 |
PTC THERAPEUTICS INC. | PTCT | Reeve Emma Director |
14,000 | $0 | 21,528 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 4:12 pm |
N/A 2033-01-04 |
PTC THERAPEUTICS INC. | PTCT | STEELE GLENN JR MD PHD Director |
14,000 | $0 | 20,500 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 4:10 pm |
N/A 2033-01-04 |
PTC THERAPEUTICS INC. | PTCT | SOUTHWELL DAVID P Director |
14,000 | $0 | 20,500 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 4:09 pm |
N/A 2033-01-04 |
PTC THERAPEUTICS INC. | PTCT | Smith Mary L. Director |
14,000 | $0 | 19,813 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 4:08 pm |
N/A 2033-01-04 |
PTC THERAPEUTICS INC. | PTCT | Okey Stephanie Director |
14,000 | $0 | 15,867 (Direct) |
View |
2022-10-17 Exercise |
2022-10-19 4:09 pm |
N/A 2026-01-03 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
6,901 | $30.86 | 664,691 (Direct) |
View |
2022-09-20 Exercise |
2022-09-22 4:38 pm |
N/A 2026-01-03 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
1,176 | $30.86 | 547,658 (Direct) |
View |
2022-06-09 Option Award |
2022-06-10 4:08 pm |
N/A 2032-06-08 |
PTC THERAPEUTICS INC. | PTCT | Young Alethia Director |
24,067 | $0 | 24,067 (Direct) |
View |
2022-04-13 Exercise |
2022-04-15 4:02 pm |
N/A 2027-01-02 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
2,276 | $11.23 | 479,710 (Direct) |
View |
2022-04-05 Exercise |
2022-04-07 4:03 pm |
N/A 2027-01-02 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott EXEC. VP AND CLO |
5 | $11.23 | 481,986 (Direct) |
View |
2022-02-10 Exercise |
2022-02-11 4:11 pm |
N/A 2027-01-02 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
2,282 | $11.23 | 481,991 (Direct) |
View |
2022-02-10 Exercise |
2022-02-11 4:11 pm |
N/A 2028-01-02 |
PTC THERAPEUTICS INC. | PTCT | Boulding Mark Elliott Exec. VP and CLO |
15,653 | $18.01 | 481,991 (Direct) |
View |